Estimating and interpreting the pharmacokinetic profiles of individual patients with hemophilia A or B using a population pharmacokinetic approach: communication from the SSC of the ISTH

J Thromb Haemost. 2017 Dec;15(12):2461-2465. doi: 10.1111/jth.13867. Epub 2017 Nov 9.
No abstract available

Publication types

  • Practice Guideline

MeSH terms

  • Blood Coagulation / drug effects*
  • Clinical Decision-Making
  • Coagulants / administration & dosage
  • Coagulants / pharmacokinetics*
  • Decision Support Techniques
  • Factor IX / administration & dosage
  • Factor IX / pharmacokinetics*
  • Factor VIII / administration & dosage
  • Factor VIII / pharmacokinetics*
  • Hemophilia A / blood
  • Hemophilia A / diagnosis
  • Hemophilia A / drug therapy*
  • Hemophilia B / blood
  • Hemophilia B / diagnosis
  • Hemophilia B / drug therapy*
  • Humans
  • Models, Biological*

Substances

  • Coagulants
  • Factor VIII
  • Factor IX